New York, New York (PRWEB) October 15, 2012
As women throughout the country continue to file transvaginal mesh lawsuits, a newly-released survey has found that doctors are reducing their use of vaginal mesh devices for the surgical treatment of recurrent pelvic organ prolapse (POP), Bernstein Liebhard LLP reports. The survey, which was presented at the 33rd Annual Scientific Meeting of the American Urogynecologic Society, was designed to gauge whether or not the U.S. Food & Drug Administration’s (FDA) July 2011 warning regarding transvaginal mesh complications had altered surgeon practice patterns. Of the 281 physicians who responded, 23% reported that they intended to decrease their use of vaginal mesh, while just over half (53.7%) reported changing their counseling methods to include more mesh-specific information. Some 5.9% reported not using any vaginal mesh, and 7.7% said they referred patients to a different provider for assessment of whether to use mesh. A fifth of respondents reported using transvaginal mesh only for recurrent POP.*
According to a report from Renal & Neurology News, the survey was completed in November 2011 by 281 doctors, 84% of whom were attending physicians. The majority (48.4%) were generalist obstetricians. Roughly 67% of those surveyed had at least 10 years' experience.
“We are heartened to see that doctors are heeding the FDA’s 2011 safety alert. We continue to receive inquiries from women on a daily basis who have allegedly suffered debilitating and life-changing complications following POP repair with transvaginal mesh products,” says Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices, including vaginal mesh. The firm is currently evaluating potential vaginal mesh lawsuits on behalf of women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to vaginal mesh.
Vaginal Mesh Lawsuits
In July 2011, the FDA warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The agency noted that it was not clear if POP repair with mesh is more effective than traditional non-mesh repair, and cautioned that such procedures may expose patients to greater risk. The FDA also warned that vaginal mesh complications associated with POP repair were not rare, a modification of its previous position.**
Since the FDA issued its alert in July 2011, hundreds of women have filed transvaginal mesh lawsuits alleging the manufacturers of these devices failed to provide adequate warnings about their significant risks. Several large pelvic mesh litigations are currently pending in the Southern District of West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (“ MDL No. 2327”).
Bernstein Liebhard LLP partner, Jeffrey Grand, is serving on the Plaintiffs’ Steering Committees in all of the above federal vaginal mesh litigations. In addition, Mr. Grand is serving as Co-Liason Counsel in two consolidated actions currently pending in New Jersey Superior Court, In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10.
Women who suffered complications following implantation of transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Bernstein Liebhard LLP is offering free lawsuit evaluations to any woman injured by vaginal mesh devices. A wealth of information regarding the firm's involvement with the ongoing pelvic mesh litigation can be found at Bernstein Liebhard's website, or call 1-877-779-1414 today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP